CD47 Regulation of Leukocyte Integrins during Leukocyte Trafficking
白细胞贩运过程中 CD47 对白细胞整合素的调节
基本信息
- 批准号:9105867
- 负责人:
- 金额:$ 58.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdhesionsAdhesivesAffectAffinityAlanineAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntigen-Presenting CellsAntigensAtherosclerosisAutoimmune DiseasesBindingBiochemicalBiologicalBiological AssayBlood PlateletsC-terminalCD4 Positive T LymphocytesCD47 geneCardiovascular DiseasesCell Culture SystemCell physiologyCell surfaceCellsChronicClinical TrialsColitisCollaborationsComplexDataDefectDevelopmentDiabetes MellitusDiseaseEffector CellEmployee StrikesEndotheliumEpitopesEscherichia coliExperimental Autoimmune EncephalomyelitisExtracellular MatrixExtracellular Matrix ProteinsGenerationsGlycoproteinsGoalsGraft RejectionHaptensHomeostasisHomingHost DefenseHumanHuman Cell LineHypertensionImmigrationImmuneIn VitroInflammationInflammatoryInflammatory ResponseInjuryIntegrin alpha4beta1Integrin alphaVbeta3IntegrinsIntercellular adhesion molecule 1IschemiaJurkat CellsKidneyLeukocyte TraffickingLeukocytesLigandsLung InflammationLymphocyteLymphoid TissueMalignant NeoplasmsMass Spectrum AnalysisMeasuresMediatingMediator of activation proteinMetabolic syndromeModelingMolecularMolecular ConformationMusMutagenesisNeoplasm MetastasisPeptide FragmentsPeptidesPhage DisplayPharmaceutical PreparationsPhenotypePhysiologicalPlacentaPlayProcessProteinsPublicationsReactionReagentRegulationReperfusion TherapyReportingResearch PersonnelRoleSHPS-1 proteinSamplingScanningSignal PathwaySignal TransductionSignaling MoleculeSiteSkin graftStrokeSurfaceT cell regulationT-LymphocyteT-Lymphocyte SubsetsTNF geneTechnologyTh1 CellsTherapeuticThickThrombospondin 1TissuesVascular Cell Adhesion Molecule-1basecell typechemokinecremaster musclecytokinedesignin vitro Modelin vivoinnovationinsightmigrationnovelpublic health relevancetherapeutic targettrafficking
项目摘要
DESCRIPTION (provided by applicant): Inflammation is a significant contributor to cardiovascular disease and related pathophysiological processes including stroke, hypertension, atherosclerosis, diabetes-metabolic syndrome. The activation and recruitment of effector T cell subsets into tissues is a highly regulated process that is dependent upon adhesive interactions between T cell subsets and the endothelium lining the vascularture. Therefore, our overall goal is to gain a better understanding of the mechanisms that regulate CD4+ T cell subset recruitment to sites of immune-mediated inflammation. Based on our exciting preliminary data and recent publication, we hypothesize that CD47 plays an important role in leukocyte β1 and β2 integrin adhesive functions by regulating the expression of high affinity conformations. By virtue of its effect on LFA-1 and VLA-4 integrin adhesive function and its well-documented role in immune cell homeostasis, CD47 and its ligand SIRPα play a critical role in multiple steps (arrest and migration) in the inflammatory response. The specific aims will determine the molecular mechanisms and underlying structural basis of CD47 regulation of T cell LFA-1 and VLA-4 adhesive function and its role in T effector cell functions. We propose complementary and well-characterized in vitro cell culture systems and novel CyTOF mass spectroscopy technology to dissect the biochemical and molecular signaling pathways used by CD47 in human and murine immune cells to regulate integrin function. Specifically, Specific Aim 1 will employ recently developed single cell mass spectrometry (CyTOF mass spectrometry) and standard biochemical assays to interrogate intracellular signaling pathways in CD47-/- T cells to identify defects that cause impaired integrin activation in CD47-/- leukocytes. Up to 40 cell-surface molecules, intracellular signaling molecules and mediators (cytokines) can be measured in a single sample using CyTOF to provide much more information about cell phenotypes at a single-cell level. Specific Aim 2 will address whether in trans CD47 ligands, Signal Regulatory Protein (SIRP)α, and SIRPγ, and the secreted extracellular matrix protein, thrombospondin-1, affect CD47 in cis regulation of LFA-1 and VLA4 function during T cell recruitment. In Specific Aim 3 we propose to determine the residues in CD47 that interact with β2 integrins, which may provide guidance for designing novel and innovative therapeutic target(s), and identify biological reagents that impair these interactions. These approaches and our collaborations with established investigators will generate novel insights into CD47 regulation of integrin activation and adhesive functions in T cell trafficking.
描述(由适用提供):炎症是心血管疾病和相关病理生理过程的重要原因,包括中风,高血压,动脉粥样硬化,糖尿病 - 代谢综合征。效应T细胞亚群进入组织的激活和募集是一个高度调节的过程,取决于T细胞亚群和脉管体衬里的粘合性相互作用。因此,我们的总体目标是更好地了解将CD4+ T细胞子集募集到免疫介导的感染部位的机制。根据我们令人兴奋的初步数据和最近的发表,我们假设CD47通过调节高亲和力构象的表达来表达白细胞β1和β2整合素粘合剂功能在白细胞β1和β2整合蛋白粘附功能中起重要作用。由于它对LFA-1和VLA-4整联蛋白粘附功能的影响以及其在免疫细胞稳态中有据可查的作用,CD47及其配体SIRPα在炎症反应中的多个步骤(逮捕和迁移)中起着至关重要的作用。具体目的将确定CD47调节T细胞LFA-1和VLA-4粘附功能的分子机制和基础结构基础及其在T效应细胞功能中的作用。我们提出了完整且良好的体外细胞培养系统和新型的质谱质谱技术,以剖析CD47在人和鼠类免疫细胞中用于调节整联蛋白功能的生化和分子信号通路。具体的,特定的目标1将采用最近开发的单细胞质谱法(质谱质谱)和标准的生化测定法来询问CD47 - / - T细胞中细胞内信号传导途径,以识别导致CD47 - / - 白细胞中整联蛋白激活受损的缺陷。可以在单个样品中使用Cytof在单个样品中测量多达40个细胞表面分子,细胞内信号分子和介体(细胞因子),以在单细胞水平上提供有关细胞表型的更多信息。具体的目标2将解决反式CD47配体,信号调节蛋白(SIRP)α和SIRPγ以及分泌的细胞外基质蛋白血小板蛋白1是否会影响CIS在T细胞募集过程中的LFA-1和VLA4功能中CD47。我们建议的特定目的3我们建议确定与β2整合素相互作用的CD47中的残差,这可能为设计新颖和创新的治疗靶靶标提供指导,并确定损害这些相互作用的生物试剂。这些方法以及我们与既定研究者的合作将产生对T细胞运输中整合素激活和粘合功能的CD47调节的新见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANCIS W. LUSCINSKAS其他文献
FRANCIS W. LUSCINSKAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANCIS W. LUSCINSKAS', 18)}}的其他基金
2014 Annual Meeting of the American Society for Investigative Pathology
2014年美国病理研究学会年会
- 批准号:
8716277 - 财政年份:2014
- 资助金额:
$ 58.46万 - 项目类别:
2013 Annual Meeting of the American Society for Investigative Pathology
2013年美国病理研究学会年会
- 批准号:
8527049 - 财政年份:2013
- 资助金额:
$ 58.46万 - 项目类别:
The Role of CD47 in Mononuclear Leukocyte Recruitment
CD47 在单核白细胞募集中的作用
- 批准号:
7753041 - 财政年份:2009
- 资助金额:
$ 58.46万 - 项目类别:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
内皮横向连接和白细胞运输
- 批准号:
6602438 - 财政年份:2002
- 资助金额:
$ 58.46万 - 项目类别:
ENDOTHELIAL LATERAL JUNCTIONS AND LEUKOCYTE TRAFFICKING
内皮横向连接和白细胞运输
- 批准号:
6469264 - 财政年份:2001
- 资助金额:
$ 58.46万 - 项目类别:
相似国自然基金
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活血通腑方调控NETs干预术后腹腔粘连组织纤维化新途径研究
- 批准号:82374466
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Translational Multimodal Strategy for Peri-Implant Disease Prevention
种植体周围疾病预防的转化多模式策略
- 批准号:
10736860 - 财政年份:2023
- 资助金额:
$ 58.46万 - 项目类别:
Localized mitochondrial metabolic activity in Xenopus mesendoderm cells undergoing collective cell migration
爪蟾中内胚层细胞集体细胞迁移的局部线粒体代谢活性
- 批准号:
10751722 - 财政年份:2023
- 资助金额:
$ 58.46万 - 项目类别:
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
- 批准号:
10741660 - 财政年份:2023
- 资助金额:
$ 58.46万 - 项目类别:
Phosphatase-dependent regulation of desmosome intercellular junctions
桥粒细胞间连接的磷酸酶依赖性调节
- 批准号:
10677182 - 财政年份:2023
- 资助金额:
$ 58.46万 - 项目类别:
Bacterial Adhesion Inhibition and Biofilm Disruption by Adaptive Piezoelectric Biomaterial
自适应压电生物材料抑制细菌粘附和破坏生物膜
- 批准号:
10668030 - 财政年份:2023
- 资助金额:
$ 58.46万 - 项目类别: